Owl is developing large and small molecule drugs to supercharge microglia -the immune cells of the brain, enhancing their ability to eat pathogens and brain cell debris, to protect and restore the brain from aging, injury and disease.
Our mission is to unlock a new era in hope for our courageous patients with traumatic brain injury (TBI), Alzheimer's disease (AD), and other aging-associated conditions.
Company Details
- Employees
- 3
- Founded
- -
- Address
- San Antonio, Tx 78215, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.owltherapeutics.com
- Keywords
- traumatic brain injury, brain health, therapeutics, drug development, diagnostics, Alzheimer's disease, artificial intelligence.
- HQ
- San Antonio, TX
Owl Therapeutics Questions
Owl Therapeutics's website is http://www.owltherapeutics.com
Owl Therapeutics's LinkedIn profile is https://www.linkedin.com/company/owl-therapeutics
Owl Therapeutics has
3 employees.
View email and phone details for 3
employees at Owl Therapeutics.
Owl Therapeutics's industry is
Biotechnology Research
Owl Therapeutics's top competitors are
Optoceutics,
Sarcomatrix,
Spruce Biosciences,
Gryphon Bio,
Ipa (Immunoprecise Antibodies),
Ashvattha Therapeutics, Inc.,
Synchneuro, Inc.,
Abliva Ab,
2stringz, Llc,
Vesper Bio.
Owl Therapeutics's categories are Biotechnology Research
Owl Therapeutics's founding year is 2023
